Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Hofseth Biocare ASA (GB:0Q6H)
:0Q6H
0Q6H Stock Chart & Stats
Day’s Range― - ―
52-Week Rangekr1.61 - kr3.01
Previous CloseN/A
Volume1.25K
Average Volume (3M)200.00
Market Cap
kr1.26B
Enterprise Valuekr870.32M
Total Cash (Recent Filing)15.16M
Total Debt (Recent Filing)45.64M
Price to Earnings (P/E)―
Beta0.09
Next Earnings
May 16, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.30
Shares Outstanding395,081,020
10 Day Avg. Volume426
30 Day Avg. Volume200
Standard Deviation0.11
R-Squared0.10
Alpha-0.03
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)10.70
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
---
Hofseth Biocare ASA News
PremiumCompany Announcements
Hofseth BioCare Partners with Symrise for Global Expansion
PremiumCompany Announcements
Hofseth Biocare ASA Announces Shareholding Changes Following Fund Liquidation
PremiumCompany Announcements
Hofseth Biocare ASA’s Strong 2024 Financial Performance
PremiumCompany Announcements
Hofseth BioCare ASA Expands Production with New Plant
PremiumCompany Announcements
Hofseth Biocare ASA Shows Strong Revenue GrowthPremiumCompany Announcements
Hofseth Biocare’s Breakthrough in Prostate Cancer
PremiumCompany Announcements
Hofseth BioCare Reports Strong Quarterly Growth---
Options Prices
Currently, No data available
---
Ownership Overview
―
Insiders
<0.01% Mutual Funds
― Other Institutional Investors
99.99% Public Companies and
Individual Investors
0Q6H FAQ
What was Hofseth Biocare ASA’s price range in the past 12 months?
Hofseth Biocare ASA lowest share price was kr1.60 and its highest was kr3.01 in the past 12 months.
What is Hofseth Biocare ASA’s market cap?
Hofseth Biocare ASA’s market cap is kr1.26B.
When is Hofseth Biocare ASA’s upcoming earnings report date?
Hofseth Biocare ASA’s upcoming earnings report date is May 16, 2025 which is in 82 days.
How were Hofseth Biocare ASA’s earnings last quarter?
Hofseth Biocare ASA released its earnings results on Feb 14, 2025. The company reported -kr0.102 earnings per share for the quarter, missing the consensus estimate of N/A by -kr0.102.
Is Hofseth Biocare ASA overvalued?
According to Wall Street analysts Hofseth Biocare ASA’s price is currently Overvalued.
Does Hofseth Biocare ASA pay dividends?
Hofseth Biocare ASA does not currently pay dividends.
What is Hofseth Biocare ASA’s EPS estimate?
Hofseth Biocare ASA’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Hofseth Biocare ASA have?
Hofseth Biocare ASA has 395,081,020 shares outstanding.
What happened to Hofseth Biocare ASA’s price movement after its last earnings report?
Hofseth Biocare ASA reported an EPS of -kr0.102 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Hofseth Biocare ASA?
Currently, no hedge funds are holding shares in GB:0Q6H
---
Company Description
Hofseth Biocare ASA
Hofseth BioCare ASA is a Norway based company engaged in the business of development, manufacturing, marketing and sale of marine ingredients such as oil, calcium and protein products. It is also involved in cooperation, participation, and ownership in the businesses engaged in related activities. The group operates in the business segment of producing salmon oil, soluble protein, calcium and nonwater soluble protein. The brands under the company are OmeGo, ProGo, and CalGo. The firm sells the products to various segments of the human nutrition market such as sports nutrition, supplements, and health foods, as well as to the market within nutrition to pet and feed industry. It generates the majority of the revenue from the sale of salmon oil internationally.
---
Technical Analysis
Hofseth Biocare ASA
―
Chromadex
―
Kali
―
Nutriband
―
BioNTech SE
―
RegenXBio
―
Fate Therapeutics
―
---